MD&A · 2025
In this section4 topics
Overview of Operations
Overview of Operations
Principal Capital Public Company Limited and its subsidiaries (“the Group”) would like to clarify operating results ending December 31, 2025, compared with the same period of 2024 as explained below.
In 2025, the Group’s consolidated revenues were THB 6,063.9 million, a 6.33% increase year-over-year resulting partly from the expansion of two additional hospitals in 2025 and disease outbreak in Q4 of 2025. Throughout the year 2025, the Group kept developing the competence in medical treatments to strengthen our competitiveness and have implemented various changes to our cost structures and expense reduction programs in order to cope with financial slowdown. The Group still continued our operations through four strategic pillars including; 1. business growth, 2. quality & efficiency of network, 3. medical service advancement, and 4. ESG development. The highlight activities in 2025 are as follows.
Business Growth
On January 9, 2025, Hospital Management Services Company Limited (“HMS”), a new wholly owned subsidiary of PRINH, was established with a registered capital of THB 150.0 million. HMS was founded to manage shared service operations for private hospitals. PRINH would transfer all assets, liabilities, contracts, benefits, and employees related to and used in the operations of the shared services business to HMS. This establishment and transfer were completed by March 31, 2025.
On March 5, 2025, Principal Healthcare – Kamphaengphet Co., Ltd (“PKPP”) was registered, as a new wholly owned subsidiary of Pitsanuloke Medical Co., Ltd (“PSV”). This is a greenfield hospital project in Kamphaeng Phet Province. Under construction phase, this new hospital is aimed to be an advanced secondary care provider, becoming a network hospital of PSV.
On April 8, 2025, Principal Healthcare – Kanchanaburi Co., Ltd. (“PKAN”) was founded, as a new wholly owned subsidiary of PRINH. PKAN was established to acquire ‘Thanakan Hospital’, a private hospital located in Kanchanaburi Province which was well-known for its general surgery and orthopedic services.
On June 4, 2025, PKAN completely acquired a hospital in Kanchanaburi province. The acquisition would enhance the Group’s service network to Western region and other nearby provinces, with a value of approximately THB 577.5 million
On June 13, 2025 Principal Next Co., Ltd. (“PNEXT”) invested in Serviso Healthcare Solutions Co., Ltd. (“Serviso”) by purchasing 40% shares. Serviso provides sterile processing service, medical waste sterilization service, and biomedical engineering service. This transaction would enable the Group to enter into a new healthcare-related business.
On August 22, 2025, PSV has opened new premium facilities which are “Threelux Wards” and ICU private rooms. These premium inpatient facilities integrated the following aspects: (1) luxury, (2) convenience, and (3) international standards of medical care, and were designed in accordance with JCI standards to ensure the highest level of safety for inpatients.
On August 25, 2025, Baanmhor Pongsak Company Limited, (“BMPS”), a new wholly owned subsidiary of PNEXT, was registered to operate business involving senior care and nursing home. BMPS is scheduled to commence its operations in Q1/2026, with facilities in Bangkok and vicinities. Moreover, it plans to further expand to other provinces to serve growing trend of elderly population in Thailand. This expansion can benefit from leveraging the Group’s business network for acquiring targeted customer groups in areas where the Group’s hospitals reside.
On September 29, 2025, PKPP held groundbreaking ceremony. Construction progress at the moment reached 40%, and it is expected to be completed by April 2026.
On December 19, 2025, Principal Healthcare Co., Ltd. (“PRINH”) entered into an agreement to buy approximately 57% shares of N.D.S. 34 Co., Ltd. (“NDS34”) which operates two hospitals in Nakhon Ratchasima province, Por Phat 1 Hospital (“PPAT”) and Por Phat 2 Hospital (“PKRT”). Total transaction value is around THB 673.7 million. This investment is considered a strategic partnership with Sanguantrakul Family, the original shareholder group. Both hospitals are mid-sized private hospitals with a long establishment of over 73 years. This project helps strengthen the Group’s footprint in respond to the growth of healthcare demands in the Northeastern of Thailand.
Technology Development
On March 21, 2025, Princ Hospital Suvarnabhumi (“PSUV”) was awarded by the Healthcare Accreditation Institute (Public Organization) (“HA”) at the 25th HA National Forum for (1) application of digital service in medication and blood transfusion to assure patient safety, and (2) utilization of technology to enhance the patient care of ST-elevation acute coronary syndrome (STE-ACS).
On April 11, 2025, PSUV received the Patient Safety Initiative of the Year award at the Healthcare Asia Awards 2025 for implementing CDSS (Clinical Decision Support System) in cardiology. This award was granted due to its innovative integration of state-of-the-art technology into routine clinical practice. Not only was the CDSS designed to support decision-making but the system also had the flexibility to evolve with advancements in medical science, ensuring its effectiveness as healthcare practices and technologies evolve.
On April 28, 2025, PSV successfully adopted the full EMR (Electronic Medical Record) approach, a crucial step toward an innovative & smart hospital.
On September 1, 2025, PRINC IR (PRINC Incident Report) system, developed by HMS, was officially launched. This system can generate comprehensive incident reports which can be used to enhance safety and service quality standards across the hospital network though analysis of risks in medical services.
On October 1, 2025, PRINC Refer system was officially launched in the Group network. This system was developed by HMS to enhance the patient referral system and to improve the efficiency of PRINC medical network.
On December 15, 2025, PRINC launched Vyana Edge, a cutting-edge AI browser extension designed to integrate with Electronic Health Record (EHR) platforms. It leverages advanced speech recognition and AI technologies to securely record the conversations between doctors and patients in real time and automatically convert them into structured clinical documentation.
Medical Service Advancement
On January 15, 2025, Princ Sisaket Cancer Center was officially opened to offer comprehensive cancer care in Sisaket and nearby provinces, enhancing the capability of cancer treatment in the lower part of the northeastern region.
On January 21, 2025, cardiac catheterization lab (Cath Lab) service was launched at Princ Hospital Paknampo (“PPNP”). This specialized heart center successfully treated a patient with an acute ST-elevation myocardial infarction (STEMI), reflecting PPNP's capability of providing medical care for complex diseases. This enables PPNP to be one of the leading private hospitals in the northern central region.
On January 30, 2025, PSV has been accredited by the Joint Commission International (“JCI”) for the fifth consecutive time. JCI is a globally recognized standard for healthcare quality and patient safety from the United States.
On March 21, 2025, Princ Hospital Uthai Thani (“PUTH”) received the HA Level 2 certificate (HA Level 2) from HA at the 25th HA National Forum.
On March 21, 2025, Princ Hospital Sisaket (“PSSK”) received the HA Level 3 certificate (HA Level 3) from HA at the 25th HA National Forum.
On April 11, 2025, PSUV received the award of Specialty Clinic of the Year - Thailand at the Healthcare Asia Awards 2025 for revolutionizing orthopedic care excellence, including robot-assisting surgeries, particularly in joint replacement and spine care, and the introduction of total disc replacement for cervical spine surgeries. This established PSUV as one of the leading providers of bone and joint care in Thailand.
On August 1, 2025, PSUV and PSV were awarded “Standard Stroke Center Certification (SSCC)” from the Neurological Institute of Thailand, Department of Medical Services, Ministry of Public Health.
On August 8, 2025, Virajsilp Hospital (“PCPN”) started a Hyperbaric Oxygen Therapy (“HBOT”) service. HBOT is a medical treatment allowing patients to get high level of pure medical oxygen inside a high-pressure chamber. HBOT therapy can effectively promote physical, brain, and wound recovery. PCPN is the first hospital in Chumphon Province to offer this service.
On October 20, 2025, PSSK received the 2025 accreditation for advanced life support from the National Institute for Emergency Medicine (NIEM).
On October 27, 2025, Princ Hospital Ubonratchathani (“PUBN”) received accreditation for its hemodialysis treatment standards from The Nephrology Society of Thailand.
On October 31, 2025, PUBN achieved the silver level for participating in the Healthy, Safety and Happy Workplace Project from the Department of Disease Control, Ministry of Public Health.
On November 28, 2025, PSUV and PPNP were certified for quality standards in physical therapy services by the Physical Therapy Council.
On December 27, 2025, PSV received accreditation for its hemodialysis treatment standards from The Nephrology Society of Thailand.
ESG Development
On February 27, 2025, PRINC was granted the Leading of ESG for People award at the Future Trends Awards 2025 for people development and contribution to social positive impact.
On March 13, 2025, PRINC signed a Memorandum of Understanding (MOU) with key partners, including the Petroleum and Petrochemical College, and the Hub of Waste Management for Sustainable Development, Chulalongkorn University, along with the ASEAN Vinyl Council Association. The collaboration aims to develop sustainable management for non-infectious PVC medical materials. This initiative focuses on reducing the waste while adding value to discarded materials. PSUV has been designated as the pilot hospital within PRINC Network for this non-infectious PVC plastic waste sorting and recycling project
On April 5, 2025, PSUV received three Challenge certificates of GREEN & CLEAN Hospital Challenge 2024 from the Department of Health which are (1) medical waste management, (2) efficient energy management, and (3) occupational health service and environmental management.
On April 11, 2025, PSUV received the ESG Program of the Year award at The Healthcare Asia Awards 2025 for its remarkable achievements in the past year, with efforts focusing on creating positive environmental impacts such as energy savings by installing a Chiller Plant Management System (CPMS).
On May 29, 2025, PSUV was granted two awards from the Department of Labour Protection and Welfare which were (1) Thailand Labor Management Excellence Award 2025 for the second year and (2) Thailand Safety Award 2025 for the first year.
On June 25, 2025, PRINC was granted a certificate of Carbon Footprint for Organization (“CFO”) for the fourth time. PRINC has won this award four times in a row. Carbon footprint concern is an important goal that PRINC applies to manage and reduce greenhouse gas emissions efficiently, in alignment with the Sustainable Development Goals.
On July 21, 2025, PPNP was granted the CSR Award 2025 from the Ministry of Social Development and Human Security.
On August 7, 2025, two of the Group hospitals received the certificates of GREEN & CLEAN Hospital Challenge from the Department of Health (1) Pitsanuvej Phichit Hospital (“PPCH”) received the Excellent certificate (2) PSUV received the Challenge certificate for Low Carbon and Climate Resilient Health Care.
On August 30, 2025, PUBN received the Standard certificates of GREEN & CLEAN Hospital Challenge 2024 from the Department of Health.
On September 1, 2025, PCPN was granted the Thailand Labor Management Excellent Award 2025 for the second year.
On September 1, 2025, PRINC received the certificate of ESG DNA from SET to honor organizations that promote the cultivation of sustainable business principles among employees at all levels.
On September 12, 2025, Princ Hospital Mukdahan (“PMDH”) received the Excellent certificate of GREEN & CLEAN Hospital Challenge 2024 from the Department of Health.
On September 17, 2025, PUTH received the Excellent certificate of GREEN & CLEAN Hospital Challenge from the Department of Health.
On September 22, 2025, five of the Group hospitals were granted the Human Right Awards 2025 from the Department of Rights and Liberties Protection, Ministry of Justice to recognize and honor organizations with outstanding performance in respecting human rights. Details are (1) PSV, PPNP, and PSUV, for the large-scale business organization category (outstanding achievement); (2) Princ Hospital Sakon Nakhon ("PSNK") for the medium-scale business organization category (outstanding achievement); and (3) PUTH for the small-scale business organization category (good achievement).
On October 1, 2025, PSV received the Challenge certificate of GREEN & CLEAN Hospital Challenge for Low Carbon and Climate Resilient Health Care from the Department of Health.
On October 1, 2025, Pitsanuvej Uttaradit Hospital (“PUTD”) received the Excellent certificate of GREEN & CLEAN Hospital Challenge from the Department of Health.
On November 26, 2025, PUBN received the Provincial Safety Award 2025 from Department of Labour Protection and Welfare (DLPW), Occupational Safety and Health Division. This marked the second year that PUBN received this award.
In Q4/2025, PSV was the second hospital in PRINC network to implement the project initiative for recycling used sterile PVC medical supplies. Through specialized processing and molding, these materials can be transformed into new products, such as bathroom curtains, rubber bed sheets, and bags.
Operating Results & Financial Condition
Operating Results & Profitability
Revenues from healthcare services was THB 6,053.8 million, an increase by THB 356.4 million or 6.26%. This resulted from seasonal disease outbreak in Q4 (which usually occurred in Q3). Additional sources of revenues also came from two new hospitals in our network which arePrinc Hospital Mukdahan (“PMDH”), commencing operation in December 2024, and Thanakan Hospital (“PKAN”) acquired in the second half of 2025.
Gross profit equaled THB 1,160.5 million, an increase by THB 19.8 million. However, gross profit margin slightly dropped from 20.0% to 19.14% which resulted mainly from an increase in doctor costs and other direct costs.
Net profit was deficit THB 454.6 million in 2025, a decrease by THB 781.1 million from 2024 due to property divestment in Q3 of 2024. In 2024, there were profit for the period from discontinued operations at THB 123.8 million and gain on disposal of discontinued at THB 700.8 million.
Comparing only profit (loss) for the period from continuing operations between 2024 and 2025, net loss for the period from continuing operations improved by a THB 43.5 million, from a deficit of THB 498.1 million in 2024 to a deficit of THB 454.6 million in 2025. This was attributable to an increase in revenues of hospitals and healthcare related businesses, and a decrease in selling and administrative expenses, as well as reduction in finance costs.
Although gross profit margin slightly dropped from 20.0% in 2024 to 19.1% in 2025, EBITDA margin increased from 7.09% in 2024 to 7.58% in 2025. Net profit margin from continuing operations also improved by 1.19%. These were attributable to growth of our core businesses as well as cost reduction management.
Return on assets improved from negative 1.65% to negative 1.63% for trailing-4-quarter period ending December 31, 2025. This was mainly due to active investments and expansions in hospitals and healthcare related businesses.
Return on equity for trailing-4-quarter period ending December 31, 2025 declined from 3.92% to negative 4.54% due to decrease in net profits. Such a decline was mainly from the fact that in Q3 of 2024, there was a huge gain on property divestment.
Liquidity & Capital Adequacy
At the end of December 31, 2025, current ratio was 0.56x, a decrease from 1.24x. Quick ratio also decreased from 1.08x to 0.45x. These resulted from business expansion as current assets were converted into non-current assets, and short-term borrowings were increased to support liquidity in operations.
Cash cycle day for trailing-4-quarter period ending December 31, 2025 was reduced by 5 days. This improvement was attributable to the more efficient management of receivable collection and inventory turnover, as well as the longer payment period to suppliers.
Debt to equity ratio was 0.66x, a 0.10x increase from December 31, 2024 due to increase in loans from financial institutions to support business expansions as mentioned earlier.
Interest coverage ratio improved from the same period of previous year due to improvement in EBIT and reduction of finance costs.
Asset Management Capability
Total asset turnover increased from 0.35x to 0.40x for the trailing-4-quarter period ending December 31, 2025. The increase was attributable to the divestment in the property business which had comparatively low asset turnover.
Fixed asset turnover slightly dropped from 0.59x to 0.58x. This was mainly due to active investments and expansions in hospitals and healthcare related businesses, leading to increase in fixed assets subsequently.
Debt Obligations & Off-Balance-Sheet Management
Capital expenditure commitments
Capital expenditure contracted as at the statement of financial position date but not recognised in the financial statements is as follows:
Consolidated financial statements | ||
2025 | 2024 | |
Property, plant and equipment | 871,704 | 270,241 |
Intangible asset | 13,545 | 39,754 |
Total (Thousand Baht) | 885,249 | 309,995 |
Operating lease commitments
The Group has entered into low-value assets leases agreements and short-term leases agreements with leases term less than 1 year which are non-cancellable lease agreements in respect to leases of equipment and its related service agreements. The lease terms are between 1 to 5 years. The future aggregate minimum lease payments which were not recognised as lease liabilities are as follows:
Consolidated financial statements | ||
2025 | 2024 | |
Not later than 1 year | 40,302 | 34,290 |
Later than 1 year but not later than 5 years | 12,968 | 26,149 |
Total (Thousand Baht) | 53,270 | 60,439 |
Over the past 9 years, we have successfully executed our strategic expansion. Nevertheless, current economic situation has signaled us to balance growth, profitability with disciplined cost management. We believe that this commitment can lead us through uncertain time.
Debt Securities with Financial Ratio Requirements
Debt Securities with Financial Ratio Requirements Issued?
No
Factors That May Affect Financial Condition
Factors or Incidents That May Materially Affect Financial Condition
On December 30, 2025, the Cabinet approved the monetary policy target for the year 2026, which was mutually agreed upon by The Monetary Policy Committee (“MPC”) and the Minister of Finance, to set the headline inflation target over the medium-term at 1% - 3%. The Ministry of Finance and the Bank of Thailand would coordinate to balance fiscal and monetary policies in order for sustainable growth to be in line with economic potential, and to facilitate the return of inflation to target. The 1% - 3% medium-term inflation target was deemed appropriate, as this target can effectively maintain price stability by anchoring medium-term inflation expectations. Additionally, this target range provides sufficient flexibility to accommodate inflation volatility from external and supply-side shocks.
On February 23, 2026, MPC announced the results that most committee members voted to cut the policy interest rate by 0.25% from 1.25% to 1.00%. MPC projected that downside risks to headline inflation increased relative to previous assessment due to energy price increase. Moreover, THB has appreciated against the U.S. dollar given the U.S. Federal Reserve’s policy interest rate outlook. The appreciation has tightened financial conditions for exporters, particularly for products facing intense price competition and low profit margins. The Committee expressed concern over signs of exchange rate misalignment from economic fundamentals. Most members deemed the policy rate cut would support the economic recovery and further alleviate debt burden as well as anchor medium-term inflation expectations.
Under these current uncertainties, PRINC continues to evaluate and mitigate various types of risks both from internal and external, in order to take proactive measures for all downside circumstances.
PRINC is continuously focusing on growth and expansions, with key strategies as follows:
Expanding hospital business to enhance our competitive networks that provide medical treatments and serve unmet demand in selected areas/provinces.
Investing in healthcare related businesses by selective strategies such as mergers & acquisitions or greenfield to upscale our hospital business and to incorporate advanced scopes of medical services.
Expanding to new market segments such as international customers.
Enhancing our capabilities of performing sophisticated healthcare services with more specialized treatments, advancing to higher level of care.
Focusing on improvementf work processes to enhance efficiency and foster stable and sustainable growth.

